Additionally, real‐time PCR results suggested that MitoTEMPO or siTXNIP reduced BSA+PA‐induced heart failure in vitro, as evidence by a decline in BNP mRNA levels (Figure 6H, Figure S6I). This evidence concerns the gene NPPB and heart failure.